Latest 8-K filings

Suja Life, Inc. announced an Amended and Restated Credit Agreement that reduces its borrowing spread and lowers its cost of capital, with an expected $18.0 million in total interest expense for 2026.

Genworth Financial announced the return of Thomas J. McInerney as President & CEO, effective September 2, 2026, concluding an interim leadership period.

ClearSign Technologies Corporation announced operational updates for Q2 2026, highlighting increased sales of M Series burners, progress on refinery projects, and advancements in flare technology.

Edesa Biotech announced the pricing of its public offering, raising approximately $25.0 million before expenses, to fund general corporate purposes.

Valion Bio, Inc. announced final voting results from its special meeting, confirming stockholder approval for the board to implement a reverse stock split.

Primo Brands Corporation reports the resignation of director Allison Spector, effective August 18, 2026, following a decrease in ownership by ORCP Stockholders.

Dynatrace LLC, a subsidiary of Dynatrace, Inc., has issued $1.4375 billion in 0.00% Exchangeable Senior Notes due 2031, with Dynatrace, Inc. providing a full guarantee.

Ross Stores announced a strong second quarter with a 13% increase in total sales and a 10% rise in comparable store sales, significantly exceeding expectations and leading to an upward revision of its fiscal 2026 guidance.

Corebridge Financial, Inc. has issued $750 million in 5.900% Senior Notes due 2036 to refinance existing debt.

Flowers Foods reported a 4.0% decrease in net sales and a 30.3% drop in net income for its second quarter of 2026, leading to a revised, more cautious full-year outlook.

Evolution Petroleum Corporation announced the pricing of its underwritten public offering of common stock, raising approximately $12.4 million to fund an acquisition and for general corporate purposes.

The Ensign Group, Inc. has successfully amended and restated its credit agreement, increasing its revolving credit facility to $800 million and extending the maturity date to August 19, 2031.

Merchants Bancorp announced its Board of Directors has declared quarterly cash dividends for common and preferred stock, payable in October 2026.

Lifetime Brands, Inc. has successfully closed a $60 million second lien term loan and amended/extended its $200 million ABL facility, pushing both maturities to August 2031, enhancing financial flexibility.

Werewolf Therapeutics has divested its pre-clinical INDUCER and INDUKINE platforms to EMD Serono for $33 million, allowing greater focus on its WTX-124 and WTX-330 clinical programs.

Clover Health provides supplemental Q&A for Q2 2026, emphasizing the impact of its Clover Assistant AI on cohort maturation and operational efficiency, while addressing operating expense ratios and strategic market focus.

Medalist Diversified, Inc. has terminated two material definitive agreements for the acquisition of properties in Texas, with earnest money deposits to be refunded.

Flux Power Holdings, Inc. announced fiscal fourth quarter and full year results for FY26, reporting an 8.2 million revenue for the quarter, a decrease from the prior year, alongside a net loss of 2.3 million.

Scienture Holdings announced a 510% sequential revenue increase in Q2 2026, alongside a 48% year-over-year improvement in operating loss and the commercial launch of REZENOPY.

Newton Golf Company, Inc. announced a private placement of common stock, raising an initial $1 million with a total potential of up to $5 million.

RenovoRx, Inc. has received confirmation from Nasdaq that its common stock has met the minimum bid price requirement, closing a compliance matter.

Veeva Systems Inc. announced the appointment of Dan Rizzo as EVP, Sales, Consulting, and Services, effective October 2, 2026, succeeding Thomas D. Schwenger.

Lifeward Ltd. announced the appointment of three new directors, including a new Board Chair, and the resignation of a current director.

Bicycle Therapeutics plc announced the immediate resignation of Class II director Charles Swanton for personal reasons.

Merit Medical Systems, Inc. announced the appointment of Sheri Lewis as Executive Vice President of Global Operations, effective August 31, 2026, alongside a leadership reorganization.

OSI Systems announced record fiscal year 2026 revenues of $1.79 billion and record non-GAAP EPS of $10.35, alongside an expanded stock repurchase program.

Sky Harbour Group Corporation has furnished an investor presentation on August 21, 2026, providing updated information to investors, analysts, and shareholders.

United Bancorp, Inc. announced an increase in its third quarter cash dividend to $0.1975 per share, a 5.3% rise from the prior year's third quarter payment.

Integrated BioPharma's subsidiary, Manhattan Drug Company, Inc., has appointed Michael Richtmyer as its new Head of Operations, leveraging his extensive experience in manufacturing and supply chain.

Acura Pharmaceuticals received a $200,000 loan from Abuse Deterrent Pharma, LLC, bringing the total principal balance to $11,094,279, as the company faces potential operational scaling back or bankruptcy by late September 2026 without additional financing.